Form 8-K - Current report:
SEC Accession No. 0001193125-22-301136
Filing Date
2022-12-08
Accepted
2022-12-08 17:27:57
Documents
14
Period of Report
2022-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d423822d8k.htm   iXBRL 8-K 29796
2 EX-99.1 d423822dex991.htm EX-99.1 10370
6 GRAPHIC g423822g1208061310099.jpg GRAPHIC 2403
  Complete submission text file 0001193125-22-301136.txt   167487

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ew-20221206.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ew-20221206_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ew-20221206_pre.xml EX-101.PRE 10810
8 EXTRACTED XBRL INSTANCE DOCUMENT d423822d8k_htm.xml XML 3264
Mailing Address ONE EDWARDS WAY IRVINE CA 92614
Business Address ONE EDWARDS WAY IRVINE CA 92614 9492502500
Edwards Lifesciences Corp (Filer) CIK: 0001099800 (see all company filings)

EIN.: 364316614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15525 | Film No.: 221453255
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies